Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peterse

Showing results (271-280 of 339) with videos related to

Pageof 34
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 23, 2003
Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients?C Vrieling, L Collette, A Fourquet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2006
Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutationMarjanka K Schmidt, Rob A E M Tollenaar, Sanne R de Kemp, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST)A C Voogd, J L Peterse, M A Crommelin, et al.
Frontiers in Bioengineering and Biotechnology|April 25, 2025
Rational design of FVIII sialylated peptides to target Siglec-3 and Siglec-9 and improve peptide formulations for reverse vaccinesEleonora Nardini, Brigitte-Carole Keumatio Doungstop, Tania Gerpe-Amor, et al.
British Journal of Cancer|March 16, 2021
Effects of cancer screening restart strategies after COVID-19 disruptionLindy M Kregting, Sylvia Kaljouw, Lucie de Jonge, et al.
Lancet (London, England)|August 26, 1998
Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvementS Rodenhuis, D J Richel, E van der Wall, et al.
JAMA Oncology|April 29, 2021
Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant WomenGlen B Taksler, Elisabeth F P Peterse, Isarah Willems, et al.
The New England Journal of Medicine|July 4, 2003
High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancerSjoerd Rodenhuis, Marijke Bontenbal, Louk V A M Beex, et al.
Nature|August 9, 2023
Reversed Holocene temperature-moisture relationship in the Horn of AfricaA J Baxter, D Verschuren, F Peterse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Prognostic significance of macrophage infiltration in leiomyosarcomasCheng-Han Lee, Inigo Espinosa, Suzan Vrijaldenhoven, et al.
Pageof 34

Showing results (271-280 of 339) with videos related to

Sort By:
Pageof 34
European Journal of Cancer (Oxford, England : 1990)|April 23, 2003
Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients?C Vrieling, L Collette, A Fourquet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2006
Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutationMarjanka K Schmidt, Rob A E M Tollenaar, Sanne R de Kemp, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST)A C Voogd, J L Peterse, M A Crommelin, et al.
Frontiers in Bioengineering and Biotechnology|April 25, 2025
Rational design of FVIII sialylated peptides to target Siglec-3 and Siglec-9 and improve peptide formulations for reverse vaccinesEleonora Nardini, Brigitte-Carole Keumatio Doungstop, Tania Gerpe-Amor, et al.
British Journal of Cancer|March 16, 2021
Effects of cancer screening restart strategies after COVID-19 disruptionLindy M Kregting, Sylvia Kaljouw, Lucie de Jonge, et al.
Lancet (London, England)|August 26, 1998
Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvementS Rodenhuis, D J Richel, E van der Wall, et al.
JAMA Oncology|April 29, 2021
Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant WomenGlen B Taksler, Elisabeth F P Peterse, Isarah Willems, et al.
The New England Journal of Medicine|July 4, 2003
High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancerSjoerd Rodenhuis, Marijke Bontenbal, Louk V A M Beex, et al.
Nature|August 9, 2023
Reversed Holocene temperature-moisture relationship in the Horn of AfricaA J Baxter, D Verschuren, F Peterse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Prognostic significance of macrophage infiltration in leiomyosarcomasCheng-Han Lee, Inigo Espinosa, Suzan Vrijaldenhoven, et al.
Pageof 34